Nature Medicine

Papers
(The H4-Index of Nature Medicine is 168. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
SCOTUS v. reproductive health in United States1808
Rise in ambient temperature is associated with increased mortality in Latin America1579
Telemonitoring for complicated pregnancies1502
LLMs get a medical education970
Questionable role of new techniques in IVF embryo culture798
A genetic test to predict adverse drug reactions715
Easing the pain of endometriosis680
Liquid biopsies and tumor mutational burden: the cutoff conundrum657
A global metric of immune health642
Recapitulating sensory feedback in artificial skin634
In vivo gene editing for inherited vision loss606
Author Correction: Single-cell guided prenatal derivation of primary fetal epithelial organoids from human amniotic and tracheal fluids597
Not all KRAS-mutated pancreatic cancers are equal — mutant dosage matters587
The capacity of brain circuits to enhance psychiatry529
Author Correction: Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology495
The effect of geopolitical flux on antimicrobial resistance493
The inconvenient reality of AI-assisted embryo selection in IVF493
Longitudinal analysis shows how microbiome changes might influence responses to immune checkpoint blockade486
Author Correction: Financial incentives for COVID-19 vaccines in a rural low-resource setting: a cluster-randomized trial449
Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial447
Can an implanted minipump deliver for diabetes patients?446
Combating vaccine revisionism445
HIV prevention through PrEP in cisgender women445
Hippocampal network activity forecasts epileptic seizures440
Solving medicine’s data bottleneck: Nightingale Open Science431
An explainable foundation model for drug repurposing429
Pembrolizumab for advanced urothelial carcinoma: exploratory ctDNA biomarker analyses of the KEYNOTE-361 phase 3 trial425
Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial424
PD-L1 and the dawn of modern cancer immunotherapy418
How virtual reality therapy is shaping mental health415
The WHO genomics program of work for equitable implementation of human genomics for global health403
HIPAA is a misunderstood and inadequate tool for protecting medical data393
Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial390
Estimating the total effect of anthropogenic climate change on human health and wellbeing388
Promoting gender equity in the scientific and health workforce is essential to improve women’s health387
Gene-edited pig liver successfully transplanted into human385
FDA approves first drug to delay type 1 diabetes381
Supported decision-making can advance clinical research participation for people with disabilities369
Publisher Correction: Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes361
An AI chatbot for talking therapy referrals358
The uncertain science of preimplantation and prenatal genetic testing358
Author Correction: Digital consults in heart failure care: a randomized controlled trial351
The role of research in China’s successful elimination of malaria350
Author Correction: Unexplained post-acute infection syndromes346
AI as a new paradigm for risk-based screening for breast cancer345
CanScreen5, a global repository for breast, cervical and colorectal cancer screening programs343
Ending the taboo on periods and period problems339
Remotely delivered weight management for people with long COVID and overweight: the randomized wait-list-controlled ReDIRECT trial335
Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma334
Author Correction: Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial333
Continuous glucose monitoring and intrapersonal variability in fasting glucose331
A cerebrospinal fluid synaptic protein biomarker for prediction of cognitive resilience versus decline in Alzheimer’s disease330
Patritumab deruxtecan in leptomeningeal metastatic disease of solid tumors: the phase 2 TUXEDO-3 trial329
Targeting the angiopoietin-like protein 3/8 complex with a monoclonal antibody in patients with mixed hyperlipidemia: a phase 1 trial329
In utero origin of myelofibrosis presenting in adult monozygotic twins326
Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial323
First tumor-agnostic approval for an ADC322
Education of healthcare professionals to improve guideline adherence in atrial fibrillation: the STEEER-AF cluster-randomized clinical trial320
Licensed H5N1 vaccines generate cross-neutralizing antibodies against highly pathogenic H5N1 clade 2.3.4.4b influenza virus317
Anemia in women — an intractable problem that requires innovative solutions313
Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial313
Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease313
IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial311
Integrated image-based deep learning and language models for primary diabetes care306
Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and identification of SARS-CoV-2 variants304
Pregnant and lactating women should be included in clinical trials for cardiovascular disease303
Will ChatGPT transform healthcare?299
In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial297
Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19296
Low-voltage-area ablation for persistent atrial fibrillation: a randomized controlled trial291
Urgent action is needed to confront artemisinin partial resistance in African malaria parasites283
Estimating future heat-related and cold-related mortality under climate change, demographic and adaptation scenarios in 854 European cities281
Changing climate and socioeconomic factors contribute to global antimicrobial resistance280
A fluid biomarker accurately detects tau aggregate pathology in Alzheimer’s disease277
Concerns about the Burden of Proof studies275
Depression pathophysiology, risk prediction of recurrence and comorbid psychiatric disorders using genome-wide analyses270
Heterogeneous aging across multiple organ systems and prediction of chronic disease and mortality269
Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy268
The landscape of mRNA nanomedicine266
Integrating the environmental and genetic architectures of aging and mortality264
Targeted therapy for osteoarthritis: progress and pitfalls264
Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial262
Machine learning improves prediction of clinical outcomes for invasive breast cancers261
WHO sets research agenda for refugee and migrant health261
The Yearbook260
An anti-obesity drug from the diabetes toolbox259
Rethinking aspirin for heart health258
An outdated loophole is letting faulty lab tests hit the market258
The visible and hidden mortality caused by flooding257
Health in the Amazon257
Mapping the cellular landscape of the brain256
Acquired blood mutations cause acute kidney injury via dysregulated inflammation255
Anti-amyloid could help prevent genetic form of Alzheimer’s disease252
Steps to prevent and respond to an H5N1 epidemic in the USA251
The expanding universe of checkpoint inhibitors for nasopharyngeal cancer249
From neoadjuvant to organ-sparing immunotherapy for colorectal cancer244
Maternal diabetes and risk of attention-deficit/hyperactivity disorder in offspring in a multinational cohort of 3.6 million mother–child pairs243
An African One Health network for antimicrobial resistance and neglected tropical diseases241
Reply to Guyton, J. R. & Boden, W. E.; Schreiber, S. et al.241
Open Letter to G7 and G20 leaders: resolve global crises to secure our future241
Immune reconstitution inflammatory syndrome drives emergence of HIV drug resistance from multiple anatomic compartments in a person living with HIV237
Health benefits of calorie restriction232
A gene-by-sex interaction contributes to liver disease susceptibility in women232
Prenatal exposure to famine affects lifelong health229
How patient advocates influence health policy228
Meningioma risk stratification with a targeted gene-expression biomarker225
siRNA therapy lowers triglycerides in patients with rare condition225
The effect of embryonic genome imbalances on pregnancy224
Brain pathology of COVID-19224
Using genetics to predict toxicity of cancer immunotherapy223
Publisher Correction: Integrating liver endpoints in clinical trials of cardiovascular and kidney disease219
Menstrual health without stigma219
Coproducing health research with Indigenous peoples218
Familial confounding in the associations between maternal health and autism217
Author Correction: Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury216
Using unlabeled data to enhance fairness of medical AI214
Microbes convert plastic waste into paracetamol214
An international treaty to regulate misuse of alcohol and cannabis213
Multiomic analyses implicate a neurodevelopmental program in the pathogenesis of cerebral arachnoid cysts213
D3S-001 in advanced solid tumors with KRASG12C mutations: a phase 1 trial211
Distinct mechanisms of long-term virologic control in two HIV-infected individuals after treatment interruption of anti-retroviral therapy210
Microbiome–metabolome dynamics associated with impaired glucose control and responses to lifestyle changes207
Author Correction: Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial207
The airway microbiome mediates the interaction between environmental exposure and respiratory health in humans206
Technology-assisted cognitive-behavioral therapy for perinatal depression delivered by lived-experience peers: a cluster-randomized noninferiority trial204
Detection of early seeding of Richter transformation in chronic lymphocytic leukemia204
Smartwatch- and smartphone-based remote assessment of brain health and detection of mild cognitive impairment201
Multi-omic profiling a defined bacterial consortium for treatment of recurrent Clostridioides difficile infection201
Use of mobile diagnostics and digital clinical trials in cardiology199
Mutations in the U4 snRNA gene RNU4-2 cause one of the most prevalent monogenic neurodevelopmental disorders199
Prospective implementation of AI-assisted screen reading to improve early detection of breast cancer198
Oral obeldesivir provides postexposure protection against Marburg virus in nonhuman primates198
Ustekinumab for type 1 diabetes in adolescents: a multicenter, double-blind, randomized phase 2 trial197
Clinical AI tools must convey predictive uncertainty for each individual patient196
Strategies for shortening tuberculosis therapy196
Risk of hematological malignancies from CT radiation exposure in children, adolescents and young adults195
Peace in Colombia requires healing the scars of conflict on the mind and brain194
Advancing global antibiotic research, development and access193
Determinants of COVID-19 vaccination status and hesitancy among older adults in China193
AI-generated text may have a role in evidence-based medicine193
Mpox continues to spread in Africa and threatens global health security192
Self-improving generative foundation model for synthetic medical image generation and clinical applications192
An integrated cell atlas of the lung in health and disease191
A digital health algorithm to guide antibiotic prescription in pediatric outpatient care: a cluster randomized controlled trial190
A meta-analysis of GFR slope as a surrogate endpoint for kidney failure190
Tirzepatide cardiovascular event risk assessment: a pre-specified meta-analysis189
Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma: survival, genomic and immunologic analyses from the phase 2 PrE0505 trial188
Ulcerative colitis is characterized by a plasmablast-skewed humoral response associated with disease activity185
Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer185
Simulation-based estimates and projections of global, regional and country-level maternal mortality by cause, 1990–2050184
Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial183
Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial182
Large-scale genome-wide association study of coronary artery disease in genetically diverse populations181
Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials181
Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial181
Emerging diagnostics and therapeutics for Alzheimer disease181
Personalized brain circuit scores identify clinically distinct biotypes in depression and anxiety180
A benchmarking crisis in biomedical machine learning179
The limits of fair medical imaging AI in real-world generalization179
Genome-wide polygenic score to predict chronic kidney disease across ancestries179
Salt substitution and salt-supply restriction for lowering blood pressure in elderly care facilities: a cluster-randomized trial178
Gene therapy for alcohol-use disorder177
Could video games be good for your health?177
ALS therapy hits molecular mark but misses clinical one176
Pig-to-human transplants inch closer to reality174
A smart solution for detecting ear problems173
A human brain circuit for addiction remission173
A pinch of salt for heart disease169
The unseen climate health risks of antimicrobial resistance in urban informal settlements168
0.04219913482666